Cutler Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-203
| Closed | -$19K | – | 3939 |
|
|
2023
Q2 | $19K | Buy |
+203
| New | +$15.8K | ﹤0.01% | 1876 |
|
|
2023
Q1 | – | Sell |
-2,154
| Closed | -$138K | – | 4058 |
|
|
2022
Q4 | $106K | Sell |
2,154
-7,493
| -78% | -$306K | 0.01% | 1127 |
|
|
2022
Q3 | $313K | Buy |
9,647
+3,575
| +59% | +$147K | 0.02% | 743 |
|
|
2022
Q2 | $239K | Buy |
6,072
+5,372
| +767% | +$287K | 0.02% | 906 |
|
|
2022
Q1 | $48K | Sell |
700
-4,987
| -88% | -$365K | ﹤0.01% | 2275 |
|
|
2021
Q4 | $442K | Buy |
5,687
+3,987
| +235% | +$352K | 0.02% | 812 |
|
|
2021
Q3 | $162K | Buy |
1,700
+300
| +21% | +$31.7K | 0.01% | 1527 |
|
|
2021
Q2 | $174K | Sell |
1,400
-500
| -26% | -$59.7K | 0.01% | 1442 |
|
|
2021
Q1 | $250K | Sell |
1,900
-5,694
| -75% | -$779K | 0.01% | 1121 |
|
|
2020
Q4 | $1.01M | Buy |
7,594
+3,630
| +92% | +$439K | 0.05% | 391 |
|
|
2020
Q3 | $404K | Sell |
3,964
-2,400
| -38% | -$207K | 0.02% | 601 |
|
|
2020
Q2 | $553K | Sell |
6,364
-759
| -11% | -$60.6K | 0.04% | 464 |
|
|
2020
Q1 | $413K | Buy |
7,123
+395
| +6% | +$32.1K | 0.02% | 621 |
|
|
2019
Q4 | $622K | Buy |
6,728
+6,410
| +2,016% | +$564K | 0.04% | 375 |
|
|
2019
Q3 | $28K | Buy |
+318
| New | +$36.2K | ﹤0.01% | 1936 |
|
|
2019
Q1 | – | Sell |
-1,098
| Closed | -$93.5K | – | 4238 |
|
|
2018
Q4 | $69K | Buy |
+1,098
| New | +$75.4K | 0.01% | 1287 |
|
|
2018
Q2 | – | Sell |
-6,336
| Closed | -$341K | – | 4388 |
|
|
2018
Q1 | $255K | Buy |
6,336
+2,861
| +82% | +$140K | 0.02% | 691 |
|
|
2017
Q4 | $182K | Buy |
3,475
+1,575
| +83% | +$84.1K | 0.01% | 1022 |
|
|
2017
Q3 | $89K | Sell |
1,900
-3,800
| -67% | -$153K | ﹤0.01% | 1757 |
|
|
2017
Q2 | $201K | Buy |
5,700
+1,300
| +30% | +$40.1K | 0.01% | 1277 |
|
|
2017
Q1 | $103K | Sell |
4,400
-21,300
| -83% | -$422K | ﹤0.01% | 1711 |
|
|
2016
Q4 | $343K | Buy |
25,700
+19,900
| +343% | +$321K | 0.01% | 924 |
|
|
2016
Q3 | $107K | Sell |
5,800
-28,002
| -83% | -$493K | ﹤0.01% | 1748 |
|
|
2016
Q2 | $414K | Sell |
33,802
-5,845
| -15% | -$44K | 0.02% | 687 |
|
|
2016
Q1 | $267K | Sell |
39,647
-10,025
| -20% | -$64.1K | 0.02% | 845 |
|
|
2015
Q4 | $458K | Buy |
+49,672
| New | +$462K | 0.03% | 665 |
|
Other funds holding EXAS
AIM
Cutler Group's EXAS Position: Q3 2023 in Review
Cutler Group sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 203 shares — an estimated $19K sold.
Cutler Group first reported a position in EXAS in Q4 2015 and held it in 26 quarters. The position peaked at $1.01M in Q4 2020. 623 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.
- Cutler Group reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
- Cutler Group sold 203 Exact Sciences shares in Q3 2023, an estimated $19K.
- Cutler Group first reported a position in Exact Sciences in Q4 2015 and held it in 26 quarters.
- Cutler Group's Exact Sciences position peaked at $1.01M in Q4 2020.
- 623 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.
Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.